Clinical Trials Browser

Phase 3 × Bone Metastases × Denosumab × Clear all

NCT04550949 2020-09-22

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Phase 3 Unknown

Bone Metastases